top of page
Search

Quit Smoking Apps Compared: Success Rates, Methods, and Clinical Evidence (2026)

Quit smoking apps have moved well beyond simple cigarette counters and motivational quotes. In 2026, the strongest contenders are built on clinical psychology, and a few now have peer-reviewed research to back up their claims. But not all apps are created equal, and the gap between evidence-backed programs and tracking tools is wider than most people realise.


This comparison breaks down the leading quit smoking apps by what actually matters: published quit rates, the psychological methods they use, and the quality of evidence behind each one.


Why the Method Behind the App Matters More Than the App Itself


Most people searching for a quit smoking app focus on ratings, reviews, and interface design. Those things matter for usability, but they tell you nothing about whether the app will actually help you stop smoking. What matters is the methodology, the psychological framework the app uses to change your relationship with cigarettes.


A 2023 systematic review published in the Journal of Medical Internet Research found that only 6.1% of the 180 smoking cessation apps available had any scientific support at all (Bold et al., JMIR, 2023). That means roughly 94% of apps on the market have never been tested in a clinical setting.


The apps worth comparing are the ones that have been.


The Methods: What's Actually Being Used


The most clinically studied approaches in quit smoking apps fall into a few categories.


Acceptance and Commitment Therapy (ACT) teaches users to accept cravings without acting on them. The iCanQuit app, developed by researchers at the Fred Hutchinson Cancer Center, uses this approach. In a randomised controlled trial published in JAMA Internal Medicine, iCanQuit was found to be about 1.5 times more effective than the NCI's QuitGuide app at achieving sustained abstinence (Bricker et al., JAMA Internal Medicine, 2020).


Cognitive Behavioral Therapy (CBT) works by identifying and restructuring the distorted thought patterns that maintain the smoking habit. Thoughts like "smoking relaxes me" or "I need a cigarette to focus" are examined against evidence and replaced with more accurate beliefs.


Rational Emotive Behavior Therapy (REBT), developed by Albert Ellis in the 1950s, goes deeper than standard CBT by targeting the emotional and identity-level beliefs that keep smokers attached to cigarettes. Where CBT asks "is this thought accurate?", REBT asks "is this belief rational?" Beliefs like "I am a smoker" or "life without cigarettes will be empty" are challenged at their root.


Gamification uses progress tracking, streaks, badges, and level systems to keep users engaged. While gamification can boost app engagement, it is not itself a cessation methodology, it is a delivery mechanism.


App-by-App Comparison


QuitSure


QuitSure is a quit smoking program, that combines CBT, REBT, and guided self-hypnosis. Users keep smoking throughout the program and quit on the final day. This counter-intuitive design is deliberate: rather than triggering a deprivation response on day one, the program systematically addresses the psychological roots of addiction before the behavioural change happens.


A cross-sectional study published in JMIR Human Factors (2024) surveyed 1,286 program completers and found that 80.1% maintained prolonged abstinence for at least 30 days after completing the program (Goldgof, Mishra & Bajaj, JMIR Human Factors, 2024; doi: 10.2196/e49519). Among those still abstinent at the time of the survey, 86.4% reported no severe withdrawal symptoms (770 out of 891 respondents), and 41.9% reported no mild withdrawal symptoms either. The study's lead author, Gregory M. Goldgof, MD, PhD, is affiliated with the University of California, San Francisco.


It is worth noting the study's limitations: as a cross-sectional web survey of program completers, the results carry selection bias toward motivated users who finished the program and responded to the survey. The study itself calls for further investigation through randomised controlled trials. That said, 80.1% prolonged abstinence among completers is a notably high figure, and the published data gives QuitSure one of the strongest evidence bases among consumer cessation apps.


The app has over 3 million downloads across 150+ countries.


iCanQuit


Built on Acceptance and Commitment Therapy, iCanQuit was developed at the Fred Hutchinson Cancer Center. Its 8-level program (4 pre-quit, 4 post-quit) includes 51 ACT-based exercises designed to help users accept cravings without acting on them.


The strongest evidence for iCanQuit comes from a randomised controlled trial comparing it to the NCI's QuitGuide, published in JAMA Internal Medicine (Bricker et al., 2020). Users of iCanQuit were roughly 1.5 times more likely to achieve sustained quit rates. A follow-up study published in Addiction (Bricker et al., 2024) examined combining iCanQuit with FDA-approved cessation medications like nicotine patches and varenicline.


iCanQuit is free and publicly available, which makes it highly accessible but also means its feature set and ongoing development are limited compared to commercially funded apps.


Kwit


Kwit uses a gamification-first approach, combining CBT principles with game mechanics like levels, achievements, and motivational cards. Users progress through stages, earn badges, and track health improvements over time.


The Kwit app has been the subject of an academic study protocol: a pilot randomised controlled trial (the "Just Kwit! Study") published in the journal Trials (Chu et al., 2019), which tested the app in hospitalised young adult smokers. This protocol study described the trial design but, as of 2026, full efficacy results from a completed RCT have not been published.


Kwit's strength is engagement. Its weakness is the absence of published quit rate data from a completed clinical trial.


Smoke Free


Smoke Free is a tracking and support app that uses elements of CBT alongside daily missions, craving logging, and progress visualisation. It has a large user base and strong app store ratings.


Smoke Free was included in a content analysis study but does not have a dedicated, published clinical trial reporting quit rates. Its approach is more toolkit-oriented than program-structured: users get a set of tools rather than a sequential, guided program.


QuitGuide (NCI)


QuitGuide is a free app developed by the U.S. National Cancer Institute. It serves as a basic quit planning and tracking tool, allowing users to set a quit date, track cravings, and log moods. It has been used as the control condition in multiple randomised controlled trials, including the iCanQuit and Actify! studies.


QuitGuide is honest about what it is: a support tool, not a structured intervention. It does not use a specific therapeutic methodology. Its value is in its simplicity and the fact that it is free and government-backed.


How the Numbers Stack Up


Comparing success rates across apps requires caution. Different studies use different definitions of "quitting" (7-day point prevalence vs. 30-day prolonged abstinence vs. 6-month sustained abstinence), different populations, and different study designs. A cross-sectional survey of motivated completers cannot be directly compared to a randomised controlled trial with biochemical verification.


With that caveat, here is what the published literature shows:


QuitSure reports 80.1% prolonged abstinence at 30+ days among program completers, from a cross-sectional web survey of 1,286 users (JMIR Human Factors, 2024). iCanQuit showed roughly 1.5 times the sustained quit rate of QuitGuide in a randomised controlled trial (JAMA Internal Medicine, 2020). Kwit has a study protocol published but no completed trial results. Smoke Free has no dedicated clinical trial. QuitGuide serves as a baseline comparison tool in multiple studies.


For context, nicotine replacement therapy (patches, gums) shows long-term success rates of roughly 6-8% in real-world use (Etter & Stapleton, Tobacco Control, 2006), and quitting cold turkey without any support succeeds for about 3-5% of people long-term (Truth Initiative, 2024).


What to Look for When Choosing an App


The research across these apps points to a few principles worth considering.


First, structured programs outperform open-ended tools. Apps that guide users through a sequential process, whether it is 6 days or 8 levels, tend to produce better outcomes than apps that simply provide a set of features to use at will.


Second, the psychological method matters. Apps built on tested therapeutic frameworks like CBT, REBT, or ACT have a theoretical and, in some cases, empirical basis for their approach. Apps built primarily on gamification or tracking are engaging but unproven as cessation interventions.


Third, published evidence is the minimum bar. Any app can claim a success rate on its website. The question is whether that number has been published in a peer-reviewed journal, with a described methodology, a defined sample, and acknowledged limitations. As of 2026, very few consumer cessation apps clear this bar.


Finally, the ability to keep smoking until the last day, as QuitSure's program allows, addresses a psychological reality most other apps ignore: forcing smokers to stop on day one triggers a deprivation response that makes the process feel like sacrifice rather than liberation. Programs that address the mental architecture of addiction before demanding behavioural change report lower withdrawal symptoms and higher completion rates.


The Bottom Line


The quit smoking app market in 2026 is large, but the number of apps with clinical evidence behind them is small. If published research matters to you, and it should when your health is at stake, the list narrows quickly to a handful of apps that have actually submitted their outcomes to peer review.


The choice comes down to what you trust: gamification and engagement mechanics, acceptance-based therapy, or a psychology-based program that dismantles the mental addiction before asking you to put out your last cigarette. The data, limited as it is, suggests that the last approach produces the highest reported cessation rates.

 

References


1. Goldgof, G. M., Mishra, S., & Bajaj, K. (2024). Efficacy of the QuitSure App for Smoking Cessation in Adult Smokers: Cross-Sectional Web Survey. JMIR Human Factors, 11, e49519. https://humanfactors.jmir.org/2024/1/e49519/


2. Bricker, J. B., et al. (2020). Randomized, controlled pilot trial of a smartphone app for smoking cessation using Acceptance and Commitment Therapy. JAMA Internal Medicine, 180(11), 1507-1514.


3. Bold, K. W., et al. (2023). Smartphone apps for smoking cessation: systematic framework for app review and analysis. Journal of Medical Internet Research, 25, e45183.


4. Chu, K. H., et al. (2019). Tobacco cessation mobile app intervention (Just Kwit! Study): Protocol for a pilot randomized controlled pragmatic trial. Trials, 20(1), 147.


5. Etter, J. F., & Stapleton, J. A. (2006). Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tobacco Control, 15(4), 280-285.


 
 
bottom of page